S&P 100

S&P 100 handeln
3.571,36 PKT +18,89 PKT +0,53 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN A0AE1W

ISIN US78380F1021


Analysen zu S&P 100-Werten

Datum Rating Analyst
07.11.11 Cisco buy UBS AG
07.11.11 McDonalds buy UBS AG
07.11.11 Cisco overweight Morgan Stanley
07.11.11 Starbucks overweight Morgan Stanley
07.11.11 Intel halten Raiffeisen Centrobank AG
07.11.11 AMD (Advanced Micro Devices) neutral JP Morgan Chase & Co.
07.11.11 AMD (Advanced Micro Devices) neutral Nomura
07.11.11 Chevron halten Independent Research GmbH
04.11.11 QUALCOMM neutral Nomura
04.11.11 Starbucks buy UBS AG
04.11.11 American International Group (AIG) neutral UBS AG
04.11.11 Bank of America neutral UBS AG
04.11.11 AT&T neutral Nomura
04.11.11 Nike overweight Barclays Capital
04.11.11 Apple overweight Barclays Capital
04.11.11 Freeport-McMoRan neutral Citigroup Corp.
04.11.11 Philip Morris kaufen Raiffeisen Centrobank AG
04.11.11 Amgen halten Raiffeisen Centrobank AG
04.11.11 Linde neutral Nomura
04.11.11 QUALCOMM hold Société Générale Group S.A. (SG)
04.11.11 QUALCOMM buy D.A. Davidson & Co.
04.11.11 QUALCOMM overweight Barclays Capital
04.11.11 MasterCard overweight Barclays Capital
04.11.11 AT&T overweight Barclays Capital
04.11.11 Amazon equal-weight Barclays Capital
04.11.11 Merck overweight Barclays Capital
04.11.11 Bank of New York Mellon overweight Barclays Capital
04.11.11 QUALCOMM outperform Credit Suisse Group
04.11.11 MasterCard buy Jefferies & Company Inc.
04.11.11 Medtronic outperform Credit Suisse Group
03.11.11 QUALCOMM outperform Oppenheimer & Co. Inc.
03.11.11 Ford Motor halten Raiffeisen Centrobank AG
03.11.11 Apple kaufen Raiffeisen Centrobank AG
03.11.11 Amazon outperform RBC Capital Markets
03.11.11 QUALCOMM outperform RBC Capital Markets
03.11.11 AT&T outperform RBC Capital Markets
03.11.11 Linde buy Commerzbank Corp. & Markets
03.11.11 Pfizer halten Independent Research GmbH
03.11.11 Pfizer equal-weight Barclays Capital
03.11.11 Target overweight Barclays Capital